A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study - Thrombin inhibition in Myocardial Ischaemia (TRIM) study group,null. (Eur Heart J, 1997)